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Background: Innovations in mobile and electronic healthcare are revolutionizing the involvement of both doctors
and patients in the modern healthcare system by extending the capabilities of physiological monitoring devices.
Despite significant progress within the monitoring device industry, the widespread integration of this technology
into medical practice remains limited. The purpose of this review is to summarize the developments and clinical
utility of smart wearable body sensors.
Methods: We reviewed the literature for connected device, sensor, trackers, telemonitoring, wireless technology
and real time home tracking devices and their application for clinicians.
Results: Smart wearable sensors are effective and reliable for preventative methods in many different facets of
medicine such as, cardiopulmonary, vascular, endocrine, neurological function and rehabilitation medicine. These
sensors have also been shown to be accurate and useful for perioperative monitoring and rehabilitation medicine.
Conclusion: Although these devices have been shown to be accurate and have clinical utility, they continue to be
underutilized in the healthcare industry. Incorporating smart wearable sensors into routine care of patients could
augment physician-patient relationships, increase the autonomy and involvement of patients in regards to their
healthcare and will provide for novel remote monitoring techniques which will revolutionize healthcare
management and spending.
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Innovations in mobile and electronic healthcare are
revolutionizing the involvement of both doctors and pa-
tients in the modern healthcare system by extending the
capabilities of physiological monitoring devices [1,2]. Ex-
pansion of health information technology and consumer
e-health tools and services, such as telemonitoring plat-
form and mobile health applications [3], have created
new opportunities for individuals to participate actively
in their healthcare, and provides the opportunity for re-
mote monitoring of clinically relevant variables in non-
clinical settings [4]. These devices can be integrated into
routine care of acute and chronic diseases and provides* Correspondence: ga@neuro-digital.com
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article, unless otherwise stated.essential information for management to both the
healthcare providers and patients [5]. Studies show that
a well-informed patient improves quality of life and pa-
tient outcome because they are more likely to participate
in healthy behavioral changes [6,7]. Furthermore, the
United States spends approximately 75% of their $2 tril-
lion budget on chronic diseases per year, which make up
7 out of 10 deaths annually [8]. Chronic diseases also
have debilitating effects, which lead the nation in causes
of major disabilities and preventable illnesses [8].
The concept of remotely monitoring patients is not new
but recently a lot of attention has been placed on smart
wearable body sensors (SWS) [4,9]. Whereas other articles
have focused primarily on devices which have been used
for research or have needed a physician’s prescription, this
article expands upon the opportunities and studies with
devices that are available to all consumers. There is nowntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and the technology is more easily accessed. These devices
contain an assortment of different sensors which can be
used to monitor variables and transmit data either to a
personal device or to an online storage site. The variety of
the sensors can be attributed to the types of stimuli that
they respond to (e.g. physiological vital signs, body move-
ments, and organic substances) and their placements
(clothing, subcutaneous implant, body part accessory, etc.)
These devices have the opportunity to meet the patients’
needs by administering information in real-time to the pa-
tient’s smartphone, computer or other wireless devices
and has the potential to influence their behaviors [5,6].
Sensors allow patients to self-monitor, track, and assess
human physiological data, while also providing interfaces
and a dashboard for healthcare providers [7]. These sen-
sors are easily managed and are becoming increasingly ac-
curate and reliable for patient care [5,10,11]. The SWS’s
can also be utilized as a diagnostic tool to aid in identify-
ing and managing a myriad of diseases [7]. Current sensor
technology for vital-sign monitoring promises great bene-
fits for prevention, prediction, and management of dis-
eases. Despite significant progress within the monitoring
device industry, the widespread integration of this tech-
nology into medical practice remains limited.
The purpose of this manuscript was to evaluate exis-
ting wearable sensors and describe their current medical
applications.
We therefore used general search engines such as
Pubmed, Science Direct, and Google Scholar to ex-
tensively search for “wearable sensor”, “mHealth”,
“eHealth”, “medical sensor”, “Personal Area Network”,
“Body Area Network”, “Body Sensor Networks”, “Tracker”,
“Monitoring”, “Self Tracking” and combination of these
terms. The search was performed using pertinent Medical
Subject Heading terms. We reviewed these studies in
order to present clinical utility.
Wearable body sensors
The SWS include a wide range of wearable devices and
sensors such as accelerometers and gyroscopes, smart
fabrics and actuators, wireless communication networks
and power supplies, and data capture technology for
processing and decision support [12]. Having a wearable
device decreases the restrictions placed on their motility
and daily activities which allows monitoring in the envir-
onment of the patients directly home but also at work.
The most used and well-known sensor accelerometers
are electrochemical sensors that measure acceleration of
objects in motion along reference axes and provide basic
step and activity counts used as a quantitative assess-
ment of physical activity [11,13]. This data can be used
to obtain velocity and displacement by merging the data
with respect to time [5]. Triaxial accelerometers, whichmonitor vibrations in three planes, can detect movement
and posture, such as upright or lying down, according to
the magnitude of acceleration signals along sensitive
axes [14,15]. Gyroscopes are also another popular type
of sensor. A gyroscope is a mechanical device that
measures 3-D orientation based on the principles of an-
gular momentum. A spinning rotor tends to maintain its
orientation allowing the changes in orientation to be
calculated by integrating the angular velocity [14].
Placement of SWS is versatile and provides flexibility
and comfort for patients, which is one of the keys for
patient acceptance. There are many devices already on
the market for fitness and wellness that use consumer-
facing applications which can be easily incorporated into
clinical practice. Most sensors can either be worn or
placed on clothes. Some wearable devices can be placed
on the almost any part of the body: wrist, ankle, waist,
chest, arm, legs, etc. These sensors can detect many dif-
ferent variables such as speed, distance, steps taken,
floors climbed and calories burned [16]. Implementation
of a real-time waist-mounted tri-axial accelerometer unit
detects a range of basic daily activities, including walking
and posture [17,18]. Other possibilities for wearable sen-
sor placement include gloves, rings, necklace, brooches,
pins, earrings, and even belt buckles. These models have
been used to monitor blood oxygen saturation (SpO2),
heart rates, and record hand posture while manipulating
objects, such as eating or dressing [19,20]. A newly mar-
keted device measures body temperature through the
use of an ear probe which detects infrared radiation
from the tympanic membrane [21]. Another approach
which could be more convenient for patients is the
placement of sensors in clothing, such as a vest or shoe.
Smart Vest is a wearable physiological monitoring sys-
tem for parameters such as, heart rate, blood pressure
(BP), body temperature, galvanic skin responses, and can
even perform electrocardiograms (ECG) [22]. There are
also experimental designs, with promising preliminary
results, demonstrating that sensors (heart rate, acceler-
ation, and respiratory activity) can be incorporated into
a regular t-shirt rather than a bulky vest, which adds an-
other layer of convenience [23]. Placement in the shoe
can provide a more convenient method to measure dif-
ferences between mean foot extreme and gait stride time
for healthy gait and those with physical disorders, as well
as proved highly capable of detecting foot orientation
and position [22].
Self-tracking and monitoring
Traditionally there have been three widely accepted ap-
proaches for outpatient monitoring: patient reported
outcomes (PRO), telemonitoring and quantifying self-
hybrid models (QSHM) [24]. PRO models encourage the
patient to be proactive by allowing them to have more
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self-report a descriptive analysis of subjective data to
their provider. Unfortunately, this data can be unreliable
and inconsistent for objective measurements. Telemoni-
toring uses equipment to monitor physiological data
passively, which is then transmitted to the patient and
can also be sent to their provider. This monitoring could
extend or replace routine outpatient care in dedicated
hospital wards. Whereas PRO models report subjective
data, telemonitoring can be used to report objective data
but a limitation to this technology is that it is only cap-
able of reporting quantifiable variables. Lastly, QSHMs
have been developed in order integrate the previous
methods by allowing the patient to be able to report
their non-quantifiable variables while still having the
ability to monitor quantifiable ones. This amalgamation
mitigates the data that may be unreliable from the self-
reporting coming from the patients and bypass the limi-
tations of variables in the telemonitoring model. This
model provides the ability for a patient to better un-
derstand their healthcare by integrating complement
models that combine subjective symptoms with objective
criteria. The majority of SWS fall under the telemonitor-
ing model but a few possess the ability to allow the user
to input subjective data as well, which then follows the
QSHM model. Ideally, SWS would continue this trend
towards QSHMs.
Many individuals with chronic diseases could benefit
from having constant remote monitoring and the best
way to monitor a patient is through understanding their
interactions with their daily activities. Giving the patient
the opportunity to depart from the hospital and con-
tinue to monitor themselves will allow for a more au-
thentic representation and a more accurate assessment
of physiological data. If patients could be monitored reli-
ably away from the hospital, this could decrease the cost
associated with the length of stay (LOS), which can
greatly decrease healthcare costs and unintended conse-
quences. Shifting the paradigm from a culture of treat-
ment to one centered upon prevention.
Overview of direct clinical applications
Cardiopulmonary and vascular monitoring
The increase in reliable monitoring and reporting
coupled with the versatility of sensor placement has fa-
cilitated efforts to implement SWS in clinical settings.
Most of the attention to date has been focused on blood
pressure monitoring with at home using sensors. The
European guidelines on cardiovascular disease (CVD)
prevention recommend frequent blood pressure moni-
toring in order to prevent coronary diseases [25]. The
dominance of chronic diseases as the major global death
contributors has emerged, and The World Health
Organization (WHO) estimates there will be about 20million CVD deaths in 2015, accounting for about 30
percent of worldwide deaths [26,27]. Additionally, tele-
home monitoring has been demonstrated to improve
quality of care in patients with CVD [28]. These statis-
tics stimulated great demand worldwide for a device that
detects respiration rate, breathing patterns and fatal
breathing changes for prevention of or early detection of
CVD [28]. A new non-invasive long-term blood pressure
measurement device measures the BP continuously on
the wrist using ultrasound, a small balloon, and an actu-
ator [29]. A ring sensor has also been used to facilitate
the management of hypertension and congestive heart
failure [12].
Continuous multimodal measurement devices have
also been developed. The Advanced Medical Monitor
(AMON) system is a wristwatch model with a multi-
variable sensor device [30]. AMON contains an acceler-
ometer that continuously measures physical activity and
comprises other sensors in order to monitor BP, blood
oxygen saturation, body temperature, and can take an
ECG [31-33]. Another wrist module was developed to
measure BP by integrating a photoplethysmographic
(PPG) sensor and an ECG sensor, allowing for continu-
ous monitoring [34,35]. The Murata vital sign sensor
uses the optical absorption of hemoglobin proteins to
make measurements of pulse and blood oxygen levels,
and has two electrodes that measure the voltage differ-
ences generated by the heart. Murata’s innovative algo-
rithm also has the ability to estimate user fatigue levels
and exercise stress [36].
Multiple types of cardiac monitoring devices exist.
Some involve surgical implantation of wireless devices
that can monitor and report data to a smart phone and
other devices can give patients access to a 24 h ECG via
an adapter that acts as a phone cover. Most of the de-
vices are external and can be placed on the wrist or
around the thorax to accurately monitor cardiac func-
tion. An example of an external device is AliveCor’s inte-
grated phone case and ECG leads, which allows patients
to monitor and record their cardiac rhythms, as well as
send their information to healthcare providers [37]. This
device has been cleared by Food and Drug Administra-
tion (FDA) as a Class II device and has received approval
of their 510(k) in order to be available on the market.
The University of Southern California recently published
an article regarding its reliability and utility of this
device within the cardiovascular field [38]. With increas-
ing computational capacity, storage capacity and ubiqui-
tous connectivity, smart phones enable individuals to
actively monitor their health in new locations [37]. Doc-
tors could use these types of devices in order to diagnose
early signs or cardiac abnormalities that could poten-
tially lead to better outcomes for cardiac patients. Atrial
fibrillation (Afib) is the most common cardiac disorder
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nosed with Afib until their condition worsens to the
point of heart attack, angina, stroke or heart failure. A
recent study compared AliveCor’s device to a standard
12-Lead ECG to see if it was suitable for screening silent
Afib, and found that the sensitivity and specificity were
high and provided accurate and reliable data [39]. The
cornerstone of Afib management is simply early detec-
tion and SWSs facilitate this.
Studies at Mayo Clinic using “off-the-shelf” monitors
have demonstrated the reliability and utility of accelerom-
eters to assess mobility in the elderly after surgery [10]. In
this study, they used wireless accelerometers on postope-
rative cardiac surgery patients and found a correlation be-
tween the number of steps taken in their early recovery
period, length of stay, and dismissal disposition [10].
Other multimodal sensors can monitor respiratory rate
and concurrently monitor oxygen saturation, coughing
events, and other respiratory variables. A good example
of this type of monitoring is the microwave reflecto-
metric vital signal sensing systems which have been de-
veloped to detect very weak microwaves that irradiate
and scatter off the human body [40]. A sensitive micro-
wave sensor monitors the reflected waves, which change
in phase in response to motions of the body, including
the regular displacement of the chest during breathing
or, the slight movement of the chest caused by the beat-
ing heart. This illustrates that these devices have an inte-
grated system of sensors that can be used to monitor
different variables rather than needing separate devices
for each individual variable. A recent measurement
system for drivers was introduced, where measuring
the pressure applied to a gauge embedded in a seat belt
derives the respiration rate [41]. Universal Biosensors
of Melbourne Victoria have also been working on a
creating an electrochemical sensor that can measure
prothrombin time for those patients who are taking
warfarin [42].
Glucose home monitoring
While many self-management phone applications have
been flexibly tailored to individual health requirements
through a routinely carried item, much research has
been invested in determining blood glucose levels with
wearable sensors [43]. A non-invasive continuous self-
monitoring device could greatly increase the patient’s au-
tonomy and improve the efficacy in the management of
diabetes [44]. Arm modules developed by Solianis Mon-
itoring AG are a multi-sensor approach. The medium-
length and long electrodes penetrate to deeper layers of
tissue, providing information related to changes in
glucose levels; the short electrode penetrates to the sur-
face layer, providing data related to other parameters
such as temperature and humidity [45].A recent clinical trial sponsored by the University of
Virginia studied the feasibility of a portable pancreas
system in patients with type one diabetes mellitus [46].
Their method utilized a combination of a monitoring
device and insulin pump to monitor their patients, along
with a computer algorithm that incorporated a closed-
loop control platform via a smart phone to modulate the
concentration of insulin. Twenty participants were mon-
itored over a 42 hour period and this study demon-
strated that a smart phone was capable of operating as
an outpatient closed-loop control device, which was
comparable to an inpatient setting using a laptop config-
uration. This study supports the idea that physicians can
accurately monitor their patients remotely and increases
the patient’s quality of life by allowing a method of con-
stant monitoring without having to check their glucose
levels periodically.
A recent innovation, that further accommodates indi-
viduals that are constantly monitoring their glucose
levels, is a non-invasive ocular glucose sensor. Although
this technology is still under development, many com-
panies are creating contact lenses that have an integrated
diagnostic sensor that detects glucose levels and trans-
mits them to a personal device. Some versions of this
glucose monitor use tears as a source of energy [47].
Google has recently taken their prototype to the FDA
for early independent clinical trials [48]. Their product
checks the ocular glucose levels every second and they
are also experimenting with placement of a light-
emitting diode (LED) light that will shine when glucose
levels are not within a particular range. Although this
technology is still years away from being released for
consumers, it acknowledges that there is a demand from
the consumer for more convenient methods to increase
their quality of life.
Neurological function monitoring
One area that has great potential and has had success
with SWS is neurological monitoring; specifically in
post-operative management, outpatient care and re-
habilitation medicine. These sensors have the ability to
seamlessly analyze gait, limb paralysis, cerebral palsy,
and have diagnostic capabilities such as, early detection
of Parkinson’s (PD) and Alzheimer’s disease (AD). A
study in 2009 used two different sensors, AMP 331 and
Minimod, one placed on the lower back and another
placed superior to the right ankle, to monitor gait in
children with cerebral palsy (CP) and compared them to
matched controls [32]. This study determined that sen-
sors are a reliable method to monitor gait in children
with CP and also demonstrated that not all sensors are
accurate and reliable. The Minimod sensors were more
reliable and accurate when monitoring the average stride
length and step count with both groups compared to the
Appelboom et al. Archives of Public Health 2014, 72:28 Page 5 of 9
http://www.archpublichealth.com/content/72/1/28AMP sensors, suggesting that more research needs to be
conducted to ensure that the correct information is be-
ing used. Another study conducted in 2011 using inertial
sensors that provided auditory and visual feedback dem-
onstrated a rehabilitative approach to sensors [49]. This
study demonstrated that patients with CP related gait
disorders had a 21% residual short-term improvement in
walking speed and 8% increase in stride length with
visual feedback, as well as an average short-term im-
provement of 25% in walking speed and 13% in stride
length for auditory feedback. The results were compared
to matched controls, which did not show a measurable
change in gait [49].
Sensors can also be used to monitor seizure activity in
patients. Preliminary studies conducted at Stanford Uni-
versity Medical Center demonstrated that a wristwatch
style device named “SmartWatch" was able to detect
seven out of eight total seizures and accurately transmit-
ted this information to the patient’s caregiver [50]. While
“SmartWatch” cannot predict seizures, this sensor allows
caregivers to be alerted and react more quickly, decreas-
ing the probability of serious injury or death. Accelerom-
eters have also been used as a reliable and objective
device to monitor the free-living physical activity of 40
stroke patients [51]. Rand et al., monitored subjects for
three consecutive days and on a 6-minute walk and
found these devices to be consistent. They also mention
that the physical activity was very low, with 58% of the
participants not meeting the recommended activity
levels. This pertinent information provides both the pro-
vider and patient the objective data needed in order to
modulate and manage treatment in an effective manner
while allowing the patient the ability to stay home.
Sensors have also played a critical role in the detection
of Alzheimer’s Disease. Pathologically, these patients
undergo degeneration of the suprachiasmatic nucleus,
which effects circadian pace makers, which lead to an
impairment of temporal structure with motion behavior.
Researchers from Computer Science and Electrical En-
gineering of Rostock University and the German Center
for Neurodegenerative Diseases (DZNE) Rostock, placed
three-axis accelerometers on the ankles of 23 dyads (n =
46) consisting of diagnosed Alzheimer’s patients and
healthy control subjects [52]. The subjects were chosen
from a sample of community dwelling individuals and
were matched according to age, gender and education. A
trained medical student placed the sensors on the dyads
on the first day and would then remove them on the
third day, allowing for continuous monitoring of the
subjects. The novel algorithm was able to discern
unlabeled Alzheimer’s patients from healthy control
subjects 91% of the time; this coincides with a higher
rate than the conventional Cohen-Mansfield Agitation
Inventory [52]. The author’s state that the higher accuracydenoted in this study suggests that the spectral structure
is associated with clinical diagnosis of AD.
Much research has also been invested in monitoring
patients with PD. The contemporary clinical assessment
does not adequately reflect the patients’ actual status
during daily life. Weiss et al. initiated a project to assess
mobility in patients with PD, with the use of SWS [53].
Healthy adults and patients with PD wore a triaxial ac-
celerometer on their waist during short walks. They used
frequency-domain measures to quantify gait variability in
the daily living environment. The average stride time was
statistically significant for the PD patients than for the
controls and the walking patterns of the PD patients were
less consistent. Average stride times were reported as be-
ing highly correlated to the dominant frequency. Weiss
concluded that frequency-based measures and sensitive
estimates to stride-to-stride variability could serve as an
objective, easily calculated marker of gait variability in
real-world settings and the ease of the sensor placement
and monitoring allows this to be a feasible option.
Neurological function monitoring has been successful
in these applications and can be extended towards other
populations of diseases and disorders. The aforemen-
tioned studies demonstrate the clinical relevance and the
potential for clinical utility. The integration of SWS al-
lows the physicians to be able to detect earlier diseases,
monitor and modulate recovery of patients and create
novel therapies for rehabilitation.
Physical therapy and rehabilitation
The SWSs are able to monitor mobility in specific thera-
peutic exercises designed for rehabilitation to provide ob-
jective criteria of the progression of the patient. This
information can be used to help improve exercise tech-
niques, thereby aiding the patient to maximize therapeutic
recovery. The wearable health-monitoring device can be
integrated into a user's clothing and performs real-time
analysis of sensors' data, provides guidance and feedback
to the user, and can generate warnings based on the user's
state, level of activity, and environmental conditions [54].
Sensors have also been integrated into pulmonary re-
habilitation. This includes graded exercises, strength and
flexibility training, collaborative self-management educa-
tion, and has been shown to improve physical functioning
and life quality. Sensors are now considered an integral
component of optimal care for people with severe lung
disease [52]. Steele et al., who provide an overview of the
potential utility of motion sensors to measure physical
activity in people with chronic pulmonary diseases, con-
cluded that SWS, specifically accelerometers, have con-
siderable potential for answering questions related to
pulmonary rehabilitation, such as how to encourage
participants to engage in exercise and increase their
overall activity [55]. Accelerometers can measure the
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pulmonary rehabilitation program to promote physical ac-
tivity and exercise following program completion. While
most of the research has been devoted to sensors involv-
ing therapy, sensors for prevention and early detection as
diagnostic tools are becoming increasingly active.
Prevention and motivational aspects of sensors
The numerous advancements in SWS are primarily due to
the “quantified self” [4]. The quantified self is a movement
to incorporate technology regarding healthcare into
regular data acquisition to create more transparency
and customization, give the patients greater access and
decision making regarding their health, and improve
healthcare systems overall. The quantified self is evol-
ving the role of the patient from a minimally informed
recipient, to an active collaborator by creating better
doctor-patient partnership models [4]. The main focus of
the evolving health care model has, thus far, been in
regards to therapeutic and treatment models for sick pa-
tients. However, more patient driven health resources, like
SWS, are converging to produce a trend of increased per-
sonal health surveillance and monitoring so healthy con-
sumers can become empowered to make healthy choices
as preventative measures. According to Pew Internet Re-
search, who carried out the first U.S. national self-tracking
survey, 69% of U.S. adults track at least one health indica-
tor for themselves, or a loved one and approximately half
of them stated that tracking these variables has changed
their overall approach to health [39]. Out of the 3014 sub-
jects surveyed, 60% stated they tracked their weight, diet,
or exercise routines, 33% tracked health indicators or
symptoms like blood pressure, blood sugar, headache, or
sleep patterns, and 12% tracked health indicators or symp-
toms for a loved one. This demonstrates a growing inter-
est from the population to being able to access this
information. The SWS and other emerging patient driven
technology are particularly focusing on the earlier stages
of healthcare, targeting prevention rather than reacting to-
wards unfavorable outcomes. Consumer reflection on
SWS data could be extended to innovative perspectives to
the overall consideration of health care. The patient can
become more of an informed participant and take active
responsibility in their health by taking healthy preventative
measures. By providing health management data, the
quantified self engages healthy patients in a variety of self-
tracking and management methods that can be utilized
for disease prevention, further developing the overall
health care system.
Discussion
Table 1 summarizes the sensors that were reviewed in
this article. This narrative review intended to provide an
overview of the clinically relevant developments andutility of SWS. While increasing access to monitoring
devices for patients has great potential to augment
healthcare, this information can be misunderstood and
misused.
A major barrier for the implementation of SWS is the
reliability and efficiency of sensor systems and data pro-
cessing software [56]. Some of the studies reported in this
review had authors who were also the system developers.
This could lead to positive biases for their products and
the dearth of randomized clinical trials, either for practical
reasons or logistical ones, makes it difficult to truly
scrutinize the results. However, many studies are being
conducted to improve the reliability of sensors [56,57].
Smart wearable sensors, specifically accelerometer-based
devices, have undergone many trials to determine their ac-
curacy and precision. While accelerometers in a broad
sense have been proven effective [58], individual studies
and devices each require mean and variance determina-
tions and adjustments to gain the most accurate results
for the desired values. Some studies have even used mul-
tiple sensors on patients to combine data to achieve opti-
mal results. A study by Olguin and Pentland compared
the activity recognition accuracy of four configurations of
accelerometers from three placements; the chest, wrist,
and hip [59]. The mean and variance of the three axes
were used as inputs to a Hidden Markov model. The clas-
sifier achieved an accuracy of 65% using only one acceler-
ometer placed at the chest. By combining data from
accelerometers placed on the wrist and hip, the accuracy
increased to 87%. They also found that it is possible to ob-
tain similar results using only two accelerometers placed
on the chest and hip. Other chest-worn accelerometers
are able to detect respiratory and snoring features for
sleep apnea diagnosis [60].
Many SWS employ algorithms to transform data ob-
tained and many times the results are only estimates of
the physiological data. There are a myriad of variables that
could influence the estimates and their generalizability
needs to be confirmed by the physicians and patients. This
review attempted to use articles that demonstrated real-
world applications of these devices rather than studies
which have only been used in laboratories. The optimal
application of these devices would be to tailor each one to
the individual using them and regularly calibrate whenever
necessary. Although healthcare is always trying to increase
patient’s autonomy and create a harmonious relationship
between physicians and patients, endowed with this tech-
nology some patients could erroneously disregard the role
of the physician. This could be circumvented through
patient education and understanding of the limits of
this technology. There is no “one size fits all solution”,
and matching the right technology for a given patient
population or desired clinical objective is key to ensu-
ring sufficient perceived usefulness and uptake [61-63].
Table 1 Review of sensors
Clinical applications Location Type of Sensor Marker
Cardiopulmonary &
Vascular Monitoring
Wrist Ultrasound [29] Blood pressure




Blood pressure and heart rhythm
Finger (ring sensor) Optical (heart rate) Heart rate and temperature
Radio-frequency identification
(pulse & temp.) [12]
Arm or thigh Microwave reflectometric
cardiopulmonary [40]
Heart rate variability as a method to evaluate stress
Can be used with various
equipment units
Optical absorption sensor Blood oxygen, heart rate and rhythm, fatigue levels
and exercise stress
ECG electrodes [36]
Phone adapter Single-channel ECG [37] Heart rate and rhythms
Seat belt of a car Wire-type strain gauge [41] Heart rate and respiration rate
Glucose Home
Monitoring
Arm Multi-variable [45] Blood glucose
Subcutaneous Glucose [46] Tissue glucose
Eye Glucose [48] Ocular glucose
Neurological Function
Monitoring
Clothes Inertial sensors and accelerometers [32,51-53] Walking distance, stride distance, and step count
during stair ascent and descent
Visual feedback-glasses Inertia [49] Walking speed and stride length
Auditory feedback-
headphones
Wrist or ankle Accelerometer and motion [50] Seizure activity
Physical Therapy and
Rehabilitation
Ankle Pedometers and accelerometer [10,55] Walking distance and step counts
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systems, such as the aforementioned sensors for dia-
betic patients and AD, the adaptability of these SWS
can be used as a method to provide personalized medi-
cine to patients in novel ways that were not available
before. Rather than strict monitoring, these devices
have the ability to calculate idiosyncratic patterns that
can be used to modulate treatment and tailor it to the
specific needs of the individual. As access to these de-
vices continues to increase, the feasibility of more dir-
ect comparisons of these devices will be available.
Additionally, SWSs can still be very expensive and, to
the best of these authors’ knowledge, there have yet to
be a designation of codes for reimbursement of these de-
vices [64]. We believe that as the trend to utilize these
devices by patients and physicians continues to rise,
eventually these will be integrated into the coding sys-
tems that will allow for reimbursement of products for
consumers. With the increase in physician shortages,
some states, such as Maryland, have already started to
expand coverage through telemedicine for delivery of
health care services [65].
Legal and ethical issues such as privacy data protection
and ownership are also major concerns of any Internet-based application. The balance between the patient as
the owner of data and the documentation and use of the
data must be properly managed, with patient confidenti-
ality always at the forefront without impeding the devel-
opment of innovative solutions. Moreover, researchers
believe that SWSs introduce risks of social inclusion of
users [66]. Lastly, elderly users strive for independence
and any technology that seems to limit their independ-
ence will be met with opposition [67].
Conclusion
The evolution of SWS and their ability to track mobility,
health indicators, and symptoms have great potential
that can revolutionize the healthcare system and change
patient behavior. Driven by the quantified self, emerging
patient driven healthcare models are contributing to
shaping a positive future for healthcare with the patient
at the epicenter. Rather than a physician reacting to an
event that occurred to a patient, the SWS distributes re-
sponsibility to the patients which can lead to more per-
sonalized medicine. There has already been a host of
clinical applications involving SWS that have been ana-
lyzed, including but not limited to blood pressure, car-
diac monitoring, respiratory rate, blood electrolyte and
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and physical therapy and rehabilitation medicine. These
technologies are continuously being improved upon and
can extend into any field of medicine. However, the inte-
gration of wireless technologies requires an infrastructure
of evidence regarding reliability, validity, and responsive-
ness for each application across a range of disease and
injury related disorders while also contributing to pre-
ventative methods. Collaboration between physicians, pa-
tients, engineers, and the wireless industry is essential for
the design and optimization of inexpensive wireless sys-
tems. Further studies and clinical trials are needed to fur-
ther this research and provide better overall models for
patients. The quantified self is being pioneered by the
patients and is revolutionizing patient behavior as they
adopt healthy behavioral changes into preventative mea-
sures. These changes will alter the way that countries
utilize funds on healthcare, set guidelines for protocols re-
garding preventative and post-operative monitoring, and
augment the physician-patient relationship. Incorporating
these technologies now will facilitate the transition and in-
crease favorable outcomes in the future.
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